🟢 Indaptus Therapeutics is trading 5.89% up today with no confirmed company-specific catalyst

Indaptus Therapeutics is trading $1.26, up +5.89%, with no confirmed company-specific announcement explaining the August 11, 2026 gain.

• Investors may be positioning ahead of the expected August 12–14, 2026 quarterly report, though the timing is an estimate rather than a confirmed catalyst.
• Broader markets are mixed, offering no clear macro explanation; the early-session gain appears catalyst-uncertain and potentially momentum-driven.